Related content

Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy

By Wallach S.   Cohen S.   Reid D. M.   Hughes R. A.   Hosking D. J.   Laan R. F.   Doherty S. M.   Maricic M.   Rosen C.   Brown J.   Barton I.   Chines A. A.  

Calcified Tissue International, Vol. 67, Iss. 4, 2000-10 ,pp. : 277-285

Springer Publishing Company

Access to resources Recommend Favorite

Genetic Variations in Bone Density, Histomorphometry, and Strength in Mice

By Akhter M. P.   Iwaniec U. T.   Covey M. A.   Cullen D. M.   Kimmel D. B.   Recker R. R.  

Calcified Tissue International, Vol. 67, Iss. 4, 2000-10 ,pp. : 337-344

Springer Publishing Company

Access to resources Recommend Favorite

Quantitative Ultrasound in Adults with Cystic Fibrosis: Correlation with Bone Mineral Density and Risk of Vertebral Fractures

By Rossini M.   Viapiana O.   Marco A.   Terlizzi F.   Gatti D.   Adami S.  

Calcified Tissue International, Vol. 80, Iss. 1, 2007-01 ,pp. : 44-49

Springer Publishing Company

Access to resources Recommend Favorite

Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy

By Reid D.M.   Adami S.   Devogelaer J.-P.   Chines A.A.  

Calcified Tissue International, Vol. 69, Iss. 4, 2001-10 ,pp. : 242-247

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of Interleukin-1α Polymorphisms on Bone Mineral Density and the Risk of Vertebral Fractures

By Knudsen S.   Harsløf T.   Husted L.   Carstens M.   Stenkjær L.   Langdahl B.  

Calcified Tissue International, Vol. 80, Iss. 1, 2007-01 ,pp. : 21-30

Springer Publishing Company

Access to resources Recommend Favorite